Lasting effects of transient postinoculation tenofovir [9-R-(2-phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaques

Marilyn S. Smith, Larry Foresman, Grisel J. Lopez, John Tsay, Dominik Wodarz, Jeffrey D. Lifson, Angelina Page, Chunyang Wang, Zhuang Li, Istvan Adany, S. Buch, Norbert Bischofberger, Opendra Narayan

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

SHIV(KU2) replicates to high levels in inoculated macaques and reproducibly causes an acute depletion of CD4+ T cells. We evaluated the ability of treatment with the antiretroviral drug 9-R-(2-phosphonomethoxypropyl)adenine (PMPA; tenofovir), begun 7 days postinoculation, to inhibit viral replication and associated pathogenesis. Highly productive infection (plasma viral RNA > 106 copy eq/mL) was present and CD4 depletion had started when treatment was initiated. PMPA treatment was associated with a rapid decline in plasma viral RNA to undetectable levels, with parallel decreases in the infectivity of plasma and infectious cells in PBMCs and CSF and stabilization of CD4+T-cell levels. Viral dynamics parameters were calculated for the initial phase of exponential viral replication and the treatment-related decline in plasma viremia. Following cessation of treatment after 12 weeks, plasma viral RNA was detectable intermittently at low levels, and spliced viral transcripts were detected in lymph nodes. Although treatment was begun after viral dissemination, high viremia, and CD4 decreases had occurred, following withdrawal of PMPA, CD4+ T-cell counts normalized and stabilized in the normal range, despite persistent low-level infection. No PMPA-resistance mutations were detected. These results validate the similar viral replicative dynamics of SHIV(KU2) and HIV and SIV, and also underscore the potential for long-term modulation of viral replication patterns and clinical course by perturbation of primary infection. (C) 2000 Academic Press.

Original languageEnglish (US)
Pages (from-to)306-315
Number of pages10
JournalVirology
Volume277
Issue number2
DOIs
StatePublished - Nov 25 2000

Fingerprint

Tenofovir
Macaca mulatta
Viral RNA
Infection
Viremia
T-Lymphocytes
Therapeutics
Withholding Treatment
Macaca
CD4 Lymphocyte Count
Plasma Cells
Reference Values
Lymph Nodes
HIV
Mutation

Keywords

  • AIDS
  • Macaque
  • PMPA
  • SHIV(KU2)
  • Viral dynamics

ASJC Scopus subject areas

  • Virology

Cite this

Lasting effects of transient postinoculation tenofovir [9-R-(2-phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaques. / Smith, Marilyn S.; Foresman, Larry; Lopez, Grisel J.; Tsay, John; Wodarz, Dominik; Lifson, Jeffrey D.; Page, Angelina; Wang, Chunyang; Li, Zhuang; Adany, Istvan; Buch, S.; Bischofberger, Norbert; Narayan, Opendra.

In: Virology, Vol. 277, No. 2, 25.11.2000, p. 306-315.

Research output: Contribution to journalArticle

Smith, MS, Foresman, L, Lopez, GJ, Tsay, J, Wodarz, D, Lifson, JD, Page, A, Wang, C, Li, Z, Adany, I, Buch, S, Bischofberger, N & Narayan, O 2000, 'Lasting effects of transient postinoculation tenofovir [9-R-(2-phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaques', Virology, vol. 277, no. 2, pp. 306-315. https://doi.org/10.1006/viro.2000.0609
Smith, Marilyn S. ; Foresman, Larry ; Lopez, Grisel J. ; Tsay, John ; Wodarz, Dominik ; Lifson, Jeffrey D. ; Page, Angelina ; Wang, Chunyang ; Li, Zhuang ; Adany, Istvan ; Buch, S. ; Bischofberger, Norbert ; Narayan, Opendra. / Lasting effects of transient postinoculation tenofovir [9-R-(2-phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaques. In: Virology. 2000 ; Vol. 277, No. 2. pp. 306-315.
@article{5b7e2147c597477892a5890702c9a0e9,
title = "Lasting effects of transient postinoculation tenofovir [9-R-(2-phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaques",
abstract = "SHIV(KU2) replicates to high levels in inoculated macaques and reproducibly causes an acute depletion of CD4+ T cells. We evaluated the ability of treatment with the antiretroviral drug 9-R-(2-phosphonomethoxypropyl)adenine (PMPA; tenofovir), begun 7 days postinoculation, to inhibit viral replication and associated pathogenesis. Highly productive infection (plasma viral RNA > 106 copy eq/mL) was present and CD4 depletion had started when treatment was initiated. PMPA treatment was associated with a rapid decline in plasma viral RNA to undetectable levels, with parallel decreases in the infectivity of plasma and infectious cells in PBMCs and CSF and stabilization of CD4+T-cell levels. Viral dynamics parameters were calculated for the initial phase of exponential viral replication and the treatment-related decline in plasma viremia. Following cessation of treatment after 12 weeks, plasma viral RNA was detectable intermittently at low levels, and spliced viral transcripts were detected in lymph nodes. Although treatment was begun after viral dissemination, high viremia, and CD4 decreases had occurred, following withdrawal of PMPA, CD4+ T-cell counts normalized and stabilized in the normal range, despite persistent low-level infection. No PMPA-resistance mutations were detected. These results validate the similar viral replicative dynamics of SHIV(KU2) and HIV and SIV, and also underscore the potential for long-term modulation of viral replication patterns and clinical course by perturbation of primary infection. (C) 2000 Academic Press.",
keywords = "AIDS, Macaque, PMPA, SHIV(KU2), Viral dynamics",
author = "Smith, {Marilyn S.} and Larry Foresman and Lopez, {Grisel J.} and John Tsay and Dominik Wodarz and Lifson, {Jeffrey D.} and Angelina Page and Chunyang Wang and Zhuang Li and Istvan Adany and S. Buch and Norbert Bischofberger and Opendra Narayan",
year = "2000",
month = "11",
day = "25",
doi = "10.1006/viro.2000.0609",
language = "English (US)",
volume = "277",
pages = "306--315",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Lasting effects of transient postinoculation tenofovir [9-R-(2-phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaques

AU - Smith, Marilyn S.

AU - Foresman, Larry

AU - Lopez, Grisel J.

AU - Tsay, John

AU - Wodarz, Dominik

AU - Lifson, Jeffrey D.

AU - Page, Angelina

AU - Wang, Chunyang

AU - Li, Zhuang

AU - Adany, Istvan

AU - Buch, S.

AU - Bischofberger, Norbert

AU - Narayan, Opendra

PY - 2000/11/25

Y1 - 2000/11/25

N2 - SHIV(KU2) replicates to high levels in inoculated macaques and reproducibly causes an acute depletion of CD4+ T cells. We evaluated the ability of treatment with the antiretroviral drug 9-R-(2-phosphonomethoxypropyl)adenine (PMPA; tenofovir), begun 7 days postinoculation, to inhibit viral replication and associated pathogenesis. Highly productive infection (plasma viral RNA > 106 copy eq/mL) was present and CD4 depletion had started when treatment was initiated. PMPA treatment was associated with a rapid decline in plasma viral RNA to undetectable levels, with parallel decreases in the infectivity of plasma and infectious cells in PBMCs and CSF and stabilization of CD4+T-cell levels. Viral dynamics parameters were calculated for the initial phase of exponential viral replication and the treatment-related decline in plasma viremia. Following cessation of treatment after 12 weeks, plasma viral RNA was detectable intermittently at low levels, and spliced viral transcripts were detected in lymph nodes. Although treatment was begun after viral dissemination, high viremia, and CD4 decreases had occurred, following withdrawal of PMPA, CD4+ T-cell counts normalized and stabilized in the normal range, despite persistent low-level infection. No PMPA-resistance mutations were detected. These results validate the similar viral replicative dynamics of SHIV(KU2) and HIV and SIV, and also underscore the potential for long-term modulation of viral replication patterns and clinical course by perturbation of primary infection. (C) 2000 Academic Press.

AB - SHIV(KU2) replicates to high levels in inoculated macaques and reproducibly causes an acute depletion of CD4+ T cells. We evaluated the ability of treatment with the antiretroviral drug 9-R-(2-phosphonomethoxypropyl)adenine (PMPA; tenofovir), begun 7 days postinoculation, to inhibit viral replication and associated pathogenesis. Highly productive infection (plasma viral RNA > 106 copy eq/mL) was present and CD4 depletion had started when treatment was initiated. PMPA treatment was associated with a rapid decline in plasma viral RNA to undetectable levels, with parallel decreases in the infectivity of plasma and infectious cells in PBMCs and CSF and stabilization of CD4+T-cell levels. Viral dynamics parameters were calculated for the initial phase of exponential viral replication and the treatment-related decline in plasma viremia. Following cessation of treatment after 12 weeks, plasma viral RNA was detectable intermittently at low levels, and spliced viral transcripts were detected in lymph nodes. Although treatment was begun after viral dissemination, high viremia, and CD4 decreases had occurred, following withdrawal of PMPA, CD4+ T-cell counts normalized and stabilized in the normal range, despite persistent low-level infection. No PMPA-resistance mutations were detected. These results validate the similar viral replicative dynamics of SHIV(KU2) and HIV and SIV, and also underscore the potential for long-term modulation of viral replication patterns and clinical course by perturbation of primary infection. (C) 2000 Academic Press.

KW - AIDS

KW - Macaque

KW - PMPA

KW - SHIV(KU2)

KW - Viral dynamics

UR - http://www.scopus.com/inward/record.url?scp=0034715789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034715789&partnerID=8YFLogxK

U2 - 10.1006/viro.2000.0609

DO - 10.1006/viro.2000.0609

M3 - Article

C2 - 11080478

AN - SCOPUS:0034715789

VL - 277

SP - 306

EP - 315

JO - Virology

JF - Virology

SN - 0042-6822

IS - 2

ER -